Conmed Corp at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 11:00PM GMT
Release Date Price: €37.2 (+0.54%)
Robbie Marcus
JPMorgan Chase & Co - Analyst

Great. Thanks, everyone. Very happy to introduce our next session. I'm Robbie Marcus, med tech analyst at JPMorgan. We have Pat Beyer, CEO of CONMED.

He's going to do a presentation followed by some Q&A. Pat?

Patrick Beyer
Conmed Corp - President, Chief Executive Officer, Director

Thanks, Robbie, and thank you for joining me here today to give me an opportunity to share with you the CONMED story. I've had my first year as a CEO at CONMED on day 13 as the CEO of CONMED last year, I got to present at JPMorgan. So I'm officially a veteran here on the second time I'm presenting. Forward-looking statements. Share with you the CONMED vision.

This is something CONMED continues to line up and feels incredibly proud about. We empower health care providers worldwide to deliver exceptional outcomes to patients. And there's a focus behind this vision. And we've evolved it over time, but it hasn't changed for a number of years, and we stand behind people, both the team that CONMED has and the patients

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot